Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer

Front Oncol. 2023 Nov 23:13:1308525. doi: 10.3389/fonc.2023.1308525. eCollection 2023.
No abstract available

Keywords: NGS - next generation sequencing; NSCLC - lung adenocarcinoma - EGFR - ALK - BRAF - KRAS - RET - MET - PD-L1 - ROS1; driver mutations; liquid biopsy; molecular profiling; target therapy.

Publication types

  • Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.